arrow_up-blue blog branches consultations events facebook-icon facebook-icon2 factsheet forum-icon forum hands key link location lock mail measure menu_plus news pdf pdf2 phone policies publications related search share subjectguide twitter-icon word youtube-icon

Evidence based practice

News items that focus on evidence based practice

Highlighting evidence based practice guidelines, research and tools from across the UK.

This theme explores what it means to practise in line with best available evidence. It highlights evidence based practice guidelines, research and other tools and updates on evidence based techniques and processes from across the UK. International content from credible resources is also included.

Evidence based practice

BBC Health

Nine lifestyle changes can reduce dementia risk, study says

The BBC has reported on a Lancet study that lists nine key risk factors including lack of education, hearing loss, smoking and physical inactivity.


Pancreatic cancer patients should be offered early scans to avoid unnecessary surgery

NICE recommends the use of a more accurate scan to diagnose and determine the stage of pancreatic cancer in patients.


Age-related macular degeneration

This guideline covers diagnosing and managing age-related macular degeneration (AMD) in adults. It aims to improve the speed at which people are diagnosed and treated to prevent loss of sight. It covers pharmacological and non-pharmacological management of AMD.


Oesophago-gastric cancer: assessment and management in adults

This guideline aims to reduce variation in practice through better organisation of care and support, and improve quality of life and survival by giving advice on the most suitable treatments depending on cancer type, stage and location.


Sore throat (acute): antimicrobial prescribing

This guideline aims to limit antibiotic use and reduce antimicrobial resistance. It stresses that acute sore throat is often caused by a virus, lasts for about a week, most people get better without antibiotics, and withholding antibiotics rarely leads to complications.


NICEtalks ep.1.How can we help people with eating disorders?

In the first episode of NICEtalks, Jess Parker explains what life is really like with an eating disorder and from Professor Christopher Fairburn from Oxford's Department of Psychiatry. NICEtalks focus on current health topics.


Patients to benefit from myeloma treatment through CDF deal

Up to 1,600 patients with multiple myeloma could benefit from a new oral pill after NICE recommends ixazomib, also known as Ninlaro, for use within the Cancer Drugs Fund (CDF).

National Institute for Health Research

Intravenous antibiotics, administered over 3 hours, are linked to lower death rates in sepsis

The risk of death in adults with sepsis was 30% lower when each dose of antibiotic was given intravenously over three hours compared to a bolus or less than 60 minutes.

NIHR Signal

Stopping biological drugs for rheumatoid arthritis can lead to twice the relapse rate

It seems safer to reduce the dose of biological drugs, rather than to stop them if people with rheumatoid arthritis and their doctors want to avoid relapse. Stopping these powerful drugs caused the disease to recur in 58% of people compared with 29% who continued them.

NIHR Signal

New screening pathway could help to identify a rare, single-gene form of diabetes

A screening pathway using blood and urine tests followed by two genetic (DNA) tests identified all people with a rare subtype of diabetes called monogenic diabetes. The screening pathway performed better than current practice based on age at diagnosis and family history which misses 63%.

NIHR Signal

A primary care intervention helps older people with depression

Enhanced case management (also called collaborative care) added to primary care reduced symptoms in people with clinical depression, compared with usual primary care. The benefit was similar to other depression treatments. However, the small benefit over usual care was not sustained to 12 months.

NIHR Signal

Biological therapies for psoriasis do not increase serious infection risk

People with psoriasis who take an immune-modulating treatment are no more likely to get serious infections than people taking standard therapies. There are fears that these biological therapies raise the risk of serious infections and this has discouraged their use.

Sign up

Get the latest on quality and safety developments.